课题基金 / 基金详情

Molecular analysis of new herpesvirusinfections

Molecular analysis of new herpesvirusinfections
新疱疹病毒感染的分子分析
批准号:
09670477
负责人:
YASUKAWA Masaki
金额:
$1.92万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

YASUKAWA Masaki的其他基金

相似基金

相关文献

中文摘要
翻译
人类疱疹病毒6型(HHV-6)、7型(HHV-7)和8型(KSHV-8)是近年来分离到的新的人类疱疹病毒。在本研究中,这些疱疹病毒感染的发病机制进行了研究,重点是病毒感染的CD 4 +T淋巴细胞的功能改变。本研究的主要结果如下:1. HHV-6感染CD 4 +T淋巴细胞可导致其凋亡。在TNF-α和抗Fas抗体存在下,接种HHV-6的细胞凋亡程度增加。HHV-6通过间接机制诱导CD 4 ^+T细胞凋亡,如最近在HIV-1感染中报道的。我们研究了各种CD 4阴性细胞系对HHV-7感染的易感性,其中使用腺病毒载体将CD 4的cDNA转移到这些细胞系中。Adex 1CACD 4转导的13株细胞中,有4株细胞对HHV-7感染表现出高度易感性。这些数据有力地表明,CD 4是结合受体的主要成分, 关于我们 HHV-7.3建立了两种新的Ph染色体阳性髓系细胞系,SAS 413和SAS 527,它们具有不同的血液学特性,并显示出对HHV-6感染的明显易感性。TPA处理潜伏感染HHV-6 B的SAS 527导致HHV-6再活化。这些新的细胞系将有助于研究HHV-6诱导造血功能衰竭的机制以及HHV-6潜伏和再激活的机制.虽然CXCR 4和CCR 5似乎不是这些病毒的共受体,但在HHV-6和HHV-7感染的细胞中检测到CXCR 4的显著下调,而不是CCR 5。CXCR 4的下调导致趋化性受损,并降低了SDF-1引起的细胞内Ca^2+浓度升高水平。从HHV-6和HHV-7感染的CD 4 ^+T淋巴细胞中提取mRNA,进行北方印迹分析,结果显示CXCR 4基因转录水平显著降低,但CXCR 4 mRNA转录后稳定性没有显著改变。少
英文摘要
Human herpesvirus 6 (HHV-6), HHV-7 and KSHV (HHV-8) are new human herpesviruses which have been recently isolated. In the present study, the pathogenesis of these herpesvirus infections was investigated focusing on the functional alteration of virus-infected CD4+T lymphocytes. Results obtained from the series of the present study are as follows :1. HHV-6 infection of CD4+T lymphocytes resulted in their apoptosis. The degree of apoptosis increased when HHV-6-inoculated cells were cultured in the presence of TNF-a and anti-Fas antibody. HHV-6 induces apoptosis in CD4^+T cells by indirect mechanisms, as reported recently in HIV-1 infection.2. We examined the susceptibility to HHV-7 infection of various CD4-negative cell lines into which the cDNA for CD4 was transferred using an adenovirus vector. Out of 13 cell lines transduced with Adex1CACD4, 4 cell lines showed high susceptibility to HHV-7 infection. These data suggest strongly that CD4 is a major component of the binding receptor for … More HHV-7.3. Two novel Ph chromosome-positive myeloid cell lines, SAS4l3 and SAS527, which possess different hematologic characteristics and show distinct susceptibility to infection of HHV-6, have been established. TPA-treatment of SAS527 which was latently infected with HHV-6B resulted in reactivation of HHV-6. These novel cell lines should be useful for studying the mechanisms of HHV-6- induced hematopoietic failure and HHV-6 latency and reactivation.4. Although CXCR4 and CCR5 appeared not to be the coreceptors for these viruses, marked down-regulation of CXCR4, but not CCR5, was detected in HHV-6 and HHV-7-infected cells. Down-regulation of CXCR4 resulted in impairment of chemotaxis and a decreased level of elevation of the intracellular Ca^<2+> concentration in response to SDF-1. Northern blot analysis of mRNAs extracted from HHV-6- and HHV-7-infected CD4^+T lymphocytes demonstrated a markedly decreased level of CXCR4 gene transcription, but post-transcriptional stability of CXCR4 mRNA was not significantly altered. Less
期刊论文(23)
专著(0)
科研奖励(0)
会议论文
Yasukawa, M., et al.: "Down-regulation of CXCR4 by human herpesvirus 6 (HHV-6) and HHV-7" Journal of Immunology. (in press.).
Yasukawa, M., et al.:“人疱疹病毒 6 (HHV-6) 和 HHV-7 下调 CXCR4”免疫学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yasukawa,M.,et al.: "Human herpesvirus 7 infection of lymphoid and myeloid cell lines transduced with an adenovirus vector ・・・・・" Journal of Virology. 71. 1708-1712 (1997)
Yasukawa, M., et al.:“用腺病毒载体转导的人疱疹病毒 7 感染淋巴和骨髓细胞系……”病毒学杂志 71. 1708-1712 (1997)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Inoue, Y., et al.: "Induction of T-cell apoptosis by human herpesvirus 6" Journal of Virology. 71. 3751-3759 (1997)
Inoue, Y., et al.:“人类疱疹病毒 6 诱导 T 细胞凋亡”病毒学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Inoue,Y.,et al.: "Induction of T-cell apoptosis by human herpesvirus 6" Journal of Virology. 71. 3751-3759 (1997)
Inoue,Y.,et al.:“人类疱疹病毒 6 诱导 T 细胞凋亡”病毒学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
19
    Development of the novel gene-immunotherapy using artificial CTL targeting leukemia stem cells
    • 批准号:
      24390245
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.4万
    • 财政年份:
      2012
    • 负责人:
      YASUKAWA Masaki
    • 依托单位:
    Development of a novel cancer therapy using soluble T-cell receptor
    • 批准号:
      23659489
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2011
    • 负责人:
      YASUKAWA Masaki
    • 依托单位:
    Development of cancer immunotherapy using co-transfer of cancer-specific TCR gene and chemokine receptor gene
    • 批准号:
      21390294
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.48万
    • 财政年份:
      2009
    • 负责人:
      YASUKAWA Masaki
    • 依托单位:
    Novel hematopoietic stem cell transplantation using cancer-specific T-cell receptor gene transfer
    • 批准号:
      19390265
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.81万
    • 财政年份:
      2007
    • 负责人:
      YASUKAWA Masaki
    • 依托单位:
    国内基金
    海外基金
    HHV-6 U4基因在阿尔兹海默症中的作用研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2023
    • 负责人:
    • 依托单位:
    HHV-6逃逸RLR/MAVS介导的天然免疫应答的机制研究
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      55万元
    • 批准年份:
      2021
    • 负责人:
      汤华民
    • 依托单位:
    HHV-6通过调控宿主T细胞糖代谢促进病毒复制及免疫逃逸的机制研究
    • 批准号:
      32070945
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2020
    • 负责人:
      李凌云
    • 依托单位:
    介导HIV-1 Tat协同HHV-6增强KSHV复制的信号转导通路鉴定
    • 批准号:
      30670096
    • 项目类别:
      面上项目
    • 资助金额:
      25.0万元
    • 批准年份:
      2006
    • 负责人:
      卢春
    • 依托单位: